BOBO DONALD E JR 4
4 · Edwards Lifesciences Corp · Filed Apr 14, 2025
Insider Transaction Report
Form 4
BOBO DONALD E JR
CVP,Strategy/Corp Development
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Acquire)
2025-04-14−9,500→ 0 totalExercise: $45.28From: 2018-06-17Exp: 2025-05-16→ Common Stock (9,500 underlying) - Sale
Common Stock
2025-04-14$69.81/sh−9,500$663,196→ 47,206.371 total - Exercise/Conversion
Common Stock
2025-04-14$45.28/sh+9,500$430,129→ 56,706.371 total
Holdings
- 135,152(indirect: By Trust)
Common Stock
- 38,817.699(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $69.48 to $70.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.